SCHEMBL2492368

SCHEMBL2492368

OCCCOC(c1ccccc1O)(c1ccccc1O)c1ccccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
JAK2 O60674 1/20 0.34
GAA P10253 1/20 0.34
PTPN1 P18031 1/20 0.33
IDO1 P14902 1/20 0.33
KIF11 P52732 2/20 0.32
KDM4E B2RXH2 2/20 0.32
RECQL P46063 2/20 0.32
NPC1 O15118 1/20 0.32
CA12 O43570 1/20 0.32
GMNN O75496 1/20 0.32
EGFR P00533 1/20 0.32
CA2 P00918 1/20 0.32
FYN P06241 1/20 0.32
POLB P06746 1/20 0.32
CA3 P07451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492118 0.90 KIF11 (0.43) ALDH1A1TDP1TSHRLMNAMAPT
SCHEMBL2494529 0.89 ALDH1A1 (0.43) ALDH1A1TDP1TSHRLMNAMAPT
SCHEMBL2489496 0.80 KIF11 (0.35) ALDH1A1TDP1PTPN1KIF11KDM4E
SCHEMBL2491343 0.80 ALDH1A1 (0.36) ALDH1A1TSHRPTPN1KIF11KDM4E
SCHEMBL2491938 0.79 KIF11 (0.46) ALDH1A1TDP1TSHRLMNAMAPT
SCHEMBL2494964 0.77 ALDH1A1 (0.41) ALDH1A1TDP1TSHRLMNAGAA
SCHEMBL2489713 0.75 KIF11 (0.59) ALDH1A1TSHRKIF11RECQLALOX15
SCHEMBL2489201 0.71 KIF11 (0.42) ALDH1A1TSHRKIF11ALOX15
SCHEMBL2492412 0.71 KIF11 (0.46) TSHRKIF11ALOX15
SCHEMBL11521694 0.71 ALDH1A1 (0.45) ALDH1A1TDP1TSHRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH ALDH1A1 1292/4885TDP1 2051/4885TSHR 100/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 ALDH1A1 1031/4885TDP1 2151/4885TSHR 75/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R ALDH1A1 1187/4885TDP1 2238/4885TSHR 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.